Article
Cleveland-Immunoscintigraphy scanning, criticized in the past for poor performance in imaging metastatic disease, may have found a reliable niche in the treatment of prostate cancer.
PSMA staging is linked with higher rates of ADT, ARPI utilization in prostate cancer
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
RETAIN-2 interim data promising for dose-dense MVAC plus nivolumab in MIBC
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Casdatifan is linked with promising safety, efficacy in clear cell RCC
Anktiva under review in UK for BCG-unresponsive NMIBC with CIS